Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis – PR Newswire (press release)
Harvard School of Engineering and Applied Sciences |
Harvard bioengineers' biomaterial-based cancer immunotherapies to be developed by Novartis
PR Newswire (press release) BOSTON, March 20, 2018 /PRNewswire-USNewswire/ — The Wyss Institute for Biologically Inspired Engineering at Harvard University and the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) announced today that Novartis will have … SEAS-developed cancer immunotherapies to be commercialized by … Novartis teams up with Harvard to develop next generation … |
